Eli Lilly’s (LLY) weight-loss medications may have benefits for people suffering from Alzheimer’s disease, according to new studies. Take advantage of TipRanks Premium at 55% off! Unlock powerful ...
The Hollywood star sat down with Newsweek to discuss his next big project: upping enrollment in clinical trials.
Eli Lilly said it received marketing authorization from the European Commission for Kisunla, a treatment for early symptomatic Alzheimer's disease. Kisunla showed in a phase 3 trial that it can ...
Pharmaceutical Technology on MSN
Healthcare burden of neurological conditions “growing”, WHO warns
The WHO calls for increased policy focus on neurological disorders like Alzheimer’s disease, an indication that has seen strong treatment advancements.
Eli Lilly continues to establish its dominance in the growing market for GLP-1 therapies. The company's oral candidate for diabetes treatment and weight loss looks very promising. Even after soaring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback